Lv71
5000 积分 2023-11-15 加入
Duration of Immunotherapy in dMMR/MSI-H Metastatic Colorectal Cancer Patients
2天前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
6天前
已完结
Responsiveness to Cetuximab without Mutations inEGFR
23天前
已完结
EGFR and KRAS in Colorectal Cancer
23天前
已完结
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer
23天前
已完结
Outcomes of Older Adults With Advanced Cancer Who Prefer Quality of Life vs Prolonging Survival
1个月前
已完结
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
2个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
2个月前
已完结
Optimal choice of different neoadjuvant chemoradiotherapies for locally advanced rectal cancer: systematic review and network meta-analysis
2个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
3个月前
已完结
皖公网安备34019202002308
